Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis
This is a narrative review that synthesizes preclinical evidence on polysaccharide metabolites from kidney-tonifying traditional Chinese medicine for osteoporosis. The scope is limited to preclinical findings, as the authors do not report primary outcomes, sample sizes, or clinical trial data. The review argues that these metabolites may have potential based on mechanistic studies, but it provides no pooled effect sizes or quantitative synthesis.
The authors note that clinical translation remains limited because most findings await validation in human trials. They acknowledge that the evidence is early and incomplete, with no reported safety or tolerability data. The review does not describe a specific study population, intervention comparator, or adverse events.
Limitations include the lack of human data and the need for further validation. The authors do not report practice relevance, funding, or conflicts of interest. The synthesis is qualitative and does not support causal claims about efficacy in patients.
Clinicians should interpret these preclinical findings with caution, as they are not yet applicable to patient care. The review highlights a gap between mechanistic research and clinical practice for osteoporosis management with traditional Chinese medicine metabolites.